M&A at BofA or RX at HL - London?
I have an offer for a Summer Analyst position in M&A at Bank of America and an offer from Houlihan Lokey in restructuring (both for London). I am not sure which to pick. I have some previous experience in RX which I liked but am quite indifferent between RX or M&A. I want to exit from IB to the buy-side after 2/3 years but don't have a particular preference as to whether distressed or not. My long-term goal is to set up my own fund. My current considerations are:
HL is a Boutique: sweatshop, less brand name, but top RX team and very good exits to distressed funds
BofA is a BB: big analyst class, strong brand name but not tier 1, strong M&A team (risk of being put in a not so good industry team), large analyst class -> wider network
Does anyone have insights into conversion rates of SA to FT for the two firms?
I know that-90k all-in to Year 1 analysts, ?
How good are BofA's exits compared to HL's exits? For example, how high is the probability of receiving an offer from Oaktree on the back of HL vson the back of BofA?
Overall, I am tending towards BofA, change my mind.
Thanks for any responses!